期刊文献+

血浆内皮素-1、醛固酮在肾病综合征患儿钠潴留中的作用 被引量:1

Eeffects of Plasma Endothelin1 and Aldosterone on SodiumRetention in Children with Nephrotic Syndrome
下载PDF
导出
摘要 为探讨血浆内皮素-1(ET-1)和醛固酮(Ald)在肾病综合征患儿钠潴留中的作用,对14例肾病综合征患儿在水肿期和消肿期的血浆ET-1、Ald及血清渗透压、白蛋白(Alb)、Na+的变化进行了观测。结果显示患儿水肿期血浆ET-1比消肿期显著性升高(P<0.01),水肿期血浆Ald与消肿期无明显差异(P>0.05);血浆ET-1与血清Na+呈直线正相关(r=0.486,P<0.01),与血清Alb呈直线负相关(r=-0.490,P<0.01)。提示肾病钠潴留可能与肾排钠减少有关,ET-1在其中起了重要作用。 The effects of plasma endothelin1 (ET1) and aldosterone (Ald) on sodium retention in children with nephrotic syndrome were investigated. 14 cases were divided into the edematous stage and nonedematous stage. Plasma ET1, Ald, and serum osmolarity, albumin (Alb), and Na+ were measured in each stage. The results showed that the plasma ET1 in edemaous stage increased significantly, compared with that in noedematous stage (P<0.01). There was no significant difference in plasma Ald between the edematous stage and the nonedematous stage. Plasma ET1 was positively correlated with the serum sodium ionic concentration and negatively correlated with the serum Alb(r=0.486,P<0.01; r=0.490, P<0.01, respectively). In conclusion, the sodium retention with nephrotic syndrome might be correlated with reduction of secreted sodium in the kidney, suggesting that ET1 plays an important role in pathogenesis
出处 《华西医科大学学报》 CSCD 1998年第3期320-322,共3页 Journal of West China University of Medical Sciences
关键词 肾病综合征 内皮素-1 醛固酮 儿童 钠潴留 Nephrotic syndrome Endothelin1 Aldosterone
  • 相关文献

参考文献3

二级参考文献2

  • 1卢思广,中华儿科杂志,1994年,32卷,80页
  • 2Xie M H,Kidney Int,1990年,38卷,473页

共引文献12

同被引文献20

  • 1周锡昌.老年人心性水肿利尿剂治疗失效77例临床分析[J].江苏大学学报(医学版),2004,14(5):427-427. 被引量:2
  • 2刘喜红,易著文,陈丹,曾雪琪,黄丹琳,姜奕.肾病综合征水肿治疗效果的循证医学证据[J].中国当代儿科杂志,2007,9(2):139-143. 被引量:17
  • 3钟清,李达道,梁仁,陈孝文.成人原发性肾病综合征血容量与肾素、醛固酮、心钠素的关系[J].中华肾脏病杂志,1997,13(3):167-170. 被引量:3
  • 4Paul S. Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists[J]. Congest Heart Fail, 2002, 8(6): 307-312.
  • 5Vfnky F, Broquist M, Svedjeholm R. Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations[J]. Ann Thorac Surg, 1997, 63(4): 993-997.
  • 6Karalliedde J, Buckingham R, Starkie M, et al. Effect of various diuretic treatments on rosiglitazone-induced fluid retention[J]. J Am Soc Nephrol, 2006, 17(12): 3482-3490.
  • 7Rondon-Berrios H. New insights into the pathophysiology of edema in nephrotic syndrome[J]. Nefrologia, 2011, 31(2): 148-154.
  • 8Deschenes G, Feraille E, Doucet A. Mechanisms of edema in nephrotic syndrome: old theories and new ideas[J]. Nephrol Dial Transplant, 2003, 18(3): 454-456.
  • 9Rennings AJ, Smits P, Stewart MW, et al. Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects[J]. Diabetes Care, 2006, 29(3): 581-587.
  • 10Hoshino T, Ookawara S, Miyazawa H, et al. Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease[J] Clin Exp Nephrol, 2015, 19(2): 247-253.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部